Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | €994.50 | €1,064.7 | 7.058% |
| Boston Scientific | 77 | 0 | 11 | 0 | €39.30 | €83.22 | 111.759% |
| UnitedHealth Group Inc. | 77 | 3 | 13 | 0 | €366.40 | €369.41 | 0.822% |
| Abbott Laboratories | 69 | 0 | 10 | 0 | €91.26 | €114.37 | 25.324% |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | €112.98 | €128.14 | 13.422% |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | €45.26 | €79.22 | 75.034% |
| Insmed Inc. | 63 | 1 | 4 | 0 | €87.50 | €173.11 | 97.845% |
| Neurocrine Bioscience | 61 | 0 | 9 | 0 | €144.15 | €157.11 | 8.988% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €143.75 | €305.21 | 112.319% |
| Johnson & Johnson | 56 | 0 | 12 | 0 | €224.25 | €227.33 | 1.372% |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | €344.20 | €435.61 | 26.559% |
| Dexcom Inc. | 55 | 2 | 6 | 0 | €72.00 | €75.53 | 4.897% |
| Alnylam Pharmace. | 47 | 0 | 7 | 0 | €176.20 | €429.93 | 144.001% |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | €409.70 | €467.05 | 13.998% |
| Regeneron Pharmaceuticals Inc. | 46 | 0 | 7 | 0 | €641.40 | €721.37 | 12.469% |
| Tenet Healthcare | 44 | 0 | 12 | 0 | €220.00 | €217.45 | -1.159% |
| AbbVie Inc. | 43 | 0 | 10 | 0 | €220.80 | €228.85 | 3.647% |
| Biogen Inc. | 43 | 1 | 10 | 1 | €178.62 | €200.07 | 12.006% |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | €224.20 | €224.09 | -0.051% |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | €68.58 | €81.13 | 18.300% |
| Medtronic plc | 41 | 1 | 2 | 0 | €73.44 | €97.41 | 32.632% |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | €91.50 | €116.89 | 27.747% |
| Amgen Inc. | 36 | 2 | 2 | 0 | €333.50 | €332.22 | -0.385% |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | €118.25 | €137.44 | 16.228% |
| Cigna Corp. | 32 | 0 | 0 | 0 | €252.10 | €288.04 | 14.256% |